Biohert Chief Scientific Officer, Kristin Comella Discusses Autologous vs Allogeneic Stem Cells

Kristen Comella, interviewed by The American Investor's Kimberly Cole for a documentary on stem cell research, gives an amazing description of how Bioheart Therapies use autologous stem cell transplantation (where stem cells are taken from a patient and then given back to that same patient) versus allogeneic stem cell transplantation which is where stem cells are removed from a donor and then given to the patient. This REMOVES a lot of the controversy surrounding the allogenic stem cell research arena where there are opinions that bring moral and religious issues in to play. Fascinating differences that few people know.

Kristin Comella

Category:

Science & Technology

[superfeeed]

Go where the StemCell Investors Go,

investorstemcelldotcom